Hazards of inadequate fluconazole dosage to treat deep-seated or systemic Candida albicans infection (Q74157177)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9459405%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Hazards of inadequate fluconazole dosage to treat deep-seated or systemic Candida albicans infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9459405%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

1 reference

P G Flanagan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9459405%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

R A Barnes

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9459405%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 November 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9459405%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9459405%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9459405%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9459405%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

295-297

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9459405%20AND%20SRC:MED&resulttype=core&format=json

Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2993270-9

7 January 2021

Oral azole drugs as systemic antifungal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2993270-9

7 January 2021

Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2993270-9

7 January 2021

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2993270-9

7 January 2021

Azole drug resistance in yeasts

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2993270-9

7 January 2021

Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2993270-9

7 January 2021

Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2993270-9

7 January 2021

Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2993270-9

7 January 2021

Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2993270-9

7 January 2021

In-vitro resistance to imidazole antifungals in Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2993270-9

7 January 2021

Antifungal susceptibility testing

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2993270-9

7 January 2021

Antifungal drug susceptibility testing. Working Party of the British Society for Antimicrobial chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2993270-9

7 January 2021

Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2993270-9

7 January 2021

Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2993270-9

7 January 2021

Nosocomial candidemia: risk factors and attributable mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2993270-9

7 January 2021

Fluconazole treatment of catheter-related right-sided endocarditis caused by Candida albicans and associated with endophthalmitis and folliculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2993270-9

7 January 2021

Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2993270-9

7 January 2021

Fluconazole is removed by continuous venovenous hemofiltration in a liver transplant patient

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2993270-9

7 January 2021

10.1016/S0163-4453(97)93270-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9459405%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference